Dr. Currier is Professor of Medicine and Chief of the Division of Infectious Diseases and Co-Director of the Center for AIDS Research and Education Center (CARE) in the Department of Medicine at University of California, Los Angeles (UCLA). Since 2007 she has been Principal Investigator of the UCLA AIDS Prevention and Treatment Clinical Trials Unit. […]
Lorem ipsum dolor sit amet, magna zril at pro, ex consul indoctum evertitur mei. Vix ad prompta tibique, veri nullam tritani qui in, graeci labitur nominavi mel ad. Mel eu debet audiam efficiantur, an vix imperdiet reprimique. Iudico euismod mandamus ne mel, at errem aliquip expetenda cum. Vim eu idque elitr everti, cu porro nobis […]
Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School. He completed his clinical and research training in internal medicine and infectious diseases at Massachusetts General Hospital and was a visiting scientist at the Whitehead Institute for Biomedical Research before […]
Dr. Lifson received his M.D. from Northwestern University Medical School in 1982, then pursued residency and research fellowship training in the Department of Pathology at the Stanford University School of Medicine. He became involved in AIDS-related research in 1983, playing a key role in establishing the first program in the United States to try to […]
-archive-i4c1.0 July 5, 2017 Agenda Slides May 10, 2017 Agenda Slides Minutes April 12, 2017 Agenda Slides March 15, 2017 Slides February 15, 2017 Agenda January 18, 2017 Agenda Slides December 21, 2016 Agenda Slides November 23, 2016 Agenda Slides October 26, 2016 Agenda Minutes Slides avaialable upon individual request September 28, 2016 Agenda Minutes […]
Click the link to download the slides. Welcome and Overview (Dan Barouch, BIDMC; John Mellors, U Pitt; Nelson Michael, MHRP) Focus 1 Overview: Development Studies (John Mellors, U Pitt) Ad26/MVA Vaccine Trial in RV254 (Jintanat Ananworanich, MHRP) Ad26/MVA Vaccine Trial in FRESH (Bruce Walker, Ragon) DC Vaccine Trial in RV254 (Charles Rinaldo, U Pitt) Combined […]
CommonHealth, September 22, 2017 By: Cynthia Fernandez, CommonHealth intern It takes a cocktail of drugs to treat HIV. It could take a cocktail of antibodies to prevent HIV as well, suggests a study by Boston-based researchers published this week in Science Translational Medicine. I spoke to researcher Dr. Dan Barouch, professor of medicine at Beth Israel Deaconess […]
Science News, September 20th, 2017 By: Aimee Cunningham For certain HIV antibodies, having a buddy or two makes a big difference in the fight against the virus. Combining the antibodies, called broadly neutralizing antibodies, may stop more strains of HIV than any single one can do alone, two new studies suggest. A “triple-threat” antibody molecule […]
Science Daily, November 9th, 2016 A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR), Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine […]